India’s Biomanufacturing Landscape
Biological engineering offers a promising avenue to address the industry’s challenges and unlock new opportunities. By harnessing the power of synthetic biology, metabolic engineering, long DNA synthesis, genome editing and strain design technologies, many of the current limitations can be overcome. The accelerated engineering of microbial strains and AI driven design of optimal growth conditions, can greatly benefit the synthetic biology driven biomanufacturing sector.
To realize the full potential of biological engineering centric approach to biomanufacturing, a multi-pronged approach is required. This includes investment in research and development, development of capacity and competence, establishing public-private partnerships and so on.



As we stand at the threshold of unprecedented advancements, it is with immense pride and optimism that I warmly welcome you to our new CVJ Centre for Synthetic Biology
and Biomanufacturing. This is not just the beginning of a new institution, but the dawn of a new era, where the AI-driven design, accelerated engineering of organisms and scalable biomanufacturing converge to create products with profound social impact.
CVJ Centre is a foundry of ideas and deliverables, where biology meets engineering to create sustainable solutions for the world’s greatest challenges.
With the global biopharmaceutical market expected to surpass USD 500 billion by 2026, our focus on developing cutting-edge bio-based therapeutics comes at a time when the world needs novel solutions for personalized healthcare more than ever. In the environmental sector, the growing need for carbon capture technologies is undeniable. If global climate action is insufficient or delayed, emissions could exceed 43 billion metric tons by 2030, further exacerbating climate change and driving global temperatures beyond the 2°C threshold.
The global bio-based materials market is expected to grow from around USD16 billion in 2022 to approximately USD 50 billion by 2030, registering a CAGR of 15-20% during this period. Key bio-based materials that are expected to significantly reduce environmental footprints are bioplastics (USD 43 billion by 2026), bio-based composites widely used in the automotive and construction industries, and bio-based textiles
Synthetic biology provides the tools to engineer microorganisms capable of capturing and utilizing carbon at an industrial scale. This aligns with our biomanufacturing strengths, where the global market is set to hit USD 30 billion by 2030, offering unprecedented opportunities for sustainable production in food, energy, and materials.
We are here to push boundaries, disrupt limitations, and open new frontiers —from designing next-generation chassis to delivering bio-products. To achieve this goal, our global collaboration with leading industry partners, academic institutions, and policymakers serves as the fertile ground where groundbreaking ideas find their niche, leading to co- creation of transformative and sustainable solutions.
Our mission is to build capacity, build expertise and build enterprise. To the immensely
talented scientists and visionaries – join us to create technologies of tomorrow. Welcome to
the future !
With boundless enthusiasm,
Pawan K Dhar, Ph.D.
Executive Director,
CVJ Centre for Biotechnology and Biomanufacturing



Reg No: EKM/TC/667/2023 | Registered under The Travancore-Cochin Literary Scientific and Charitable Societies Registration Act 1955
